Table 7.
Prevalence of electrolyte disorder after bowel preparation
| Bowel preparation | Study | Number of patients | Hypokalemia | Hyponatremia | Hypernatremia | Hyperphosphatemia | Hypocalcemia |
|---|---|---|---|---|---|---|---|
| High‐volume | |||||||
| PEG 4 L | Clarkston et al. 25 | 49 | 2.0% | – | – | – | 4.1% |
| Klare et al. 27 | 101 | 2.0% | 4.0% | – | – | 11.9% | |
| Marin Gabriel et al. 29 | 25 | 28.0% | 24.0% | – | – | 8.0% | |
| Mathus‐Vliegen et al. 30 | 47 | 8.3% | 0.0% | 0.0% | 2.9% | 0.0% | |
| Rostom et al. 32 | 49 | 0.0% | 0.0% | – | 0.0% | 26.0% | |
| Low‐volume | |||||||
| NaP | Ainley et al. 22 | 100 | 26.0% | 2.0% | 0.0% | 45.0% | 16.0% |
| Beloosesky et al. 24 | 36 | 56.0% | 14.0% | – | – | 58.0% | |
| Bitoun et al. 33 | 171 | 5.8% | – | – | 5.8% | 0.6% | |
| Clarkston et al. 25 | 49 | 26.5% | – | – | 98.0% | 12.2% | |
| Lieberman et al. 28 | 32 | – | – | – | 28.1% | 6.3% | |
| Marin Gabriel et al. 29 | 17 | 23.5% | 5.9% | – | 47.1% | 12.9% | |
| Mathus‐Vliegen et al. 30 | 47 | 0.0% | 2.4% | 2.4% | 39.0% | 5.0% | |
| Rostom et al. 32 | 144 | 10.4% | 0.0% | 0.7% | 6.3% | 41.7% | |
| PEG‐asc 2L | Bitoun et al. 33 | 169 | 0.0% | − | − | 0.0% | 0.0% |
| SPMC | Klare et al. 27 | 99 | 1.0% | 21.2% | − | − | 6.1% |
NaP, sodium phosphate; PEG, polyethylene glycol; PEG‐asc, polyethylene glycol ascorbic acid; SPMC, sodium picosulfate plus magnesium citrate.